LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Receivables

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) currently reports a receivables of $500M as of March 2025. That compares with $440M in the prior-year period — up 13.0% year over year. Use the charts on this page to explore LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s receivables history and peer comparisons.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s receivables increased from $440M to $500M — a 13.0% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) reported $500M in receivables as of March 2025. That compares with $440M in the prior-year period — up 13.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $500M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028), and consider following LSBPW for alerts when major investors trade the stock.